HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102

Study Summary

This is a clinical study for GC1102 to demonstrate preventing the recurrence of hepatitis B virus (HBV) infection following liver transplantation and a dose-finding study to determine its optional dose.